← Back to Clinical Trials
Recruiting NCT06153589

NCT06153589 Effectiveness of Musicotherapy in Reducing Pain Induced by Leg Ulcer Care

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06153589
Status Recruiting
Phase
Sponsor University Hospital Center of Martinique
Condition Debridement Care
Study Type INTERVENTIONAL
Enrollment 180 participants
Start Date 2025-01-08
Primary Completion 2026-07-08

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Musicotherapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 180 participants in total. It began in 2025-01-08 with a primary completion date of 2026-07-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Venous leg ulcer is the final stage of chronic venous disease and only develops due to advanced chronic venous insufficiency. The problems caused by venous disease are initially minor and often neglected, but can impact the quality of life of patients. The prevalence of leg ulcers is estimated at 1% of the general population and 3% to 5% of subjects over 65 years old. Its prevalence increases with age in both men and women. Managing chronic ulcers requires a certain number of care procedures, including debridement. The act of treatment by mechanical debridement is little relieved by the analgesics given beforehand, and can be painful, with risks of bleeding. Musicotherapy, particularly the U-shaped method, has shown its effectiveness in the treatment of pain and anxiety in several areas (geriatrics, intensive care, rheumatology, oncology, etc.). The standardized musicotherapy method of the U-shaped sequence was developed and initially evaluated by clinical studies coordinated by the INSERM unit U1061 (Pr. Jacques Touchon; Dr. Stéphane Guétin). Following the publication of numerous controlled, randomized studies presenting results on the effectiveness in the treatment of pain and anxiety, a digital application was developed in order to standardize the method. The Music Care health application is now a Class 1 Medical Device, with CE marking obtained. This "U-shaped sequence" is standardized and has been clinically validated, which makes Music Care a unique tool available for pain relief. No studies have been found in the literature regarding the use of music therapy during debridement care.

Eligibility Criteria

Inclusion Criteria: * Adult patient, * Patient followed at the M@diCICAT healing center requiring wound debridement : * For a venous or arterial ulcer or necrotizing angiodermatitis of the lower limbs, * Having the ability to verbalize about their pain (communicating), * With a planned debridement time of less than 40 minutes. * Patient affiliated to or beneficiary of a social security scheme, * Patient having given free, informed and express consent. Exclusion Criteria: * Patient with a diabetic foot (loss of sensitivity-neuropathy), * Patient not requiring a debridement session, * Patient with an infected ulcer (abscess, etc.), * Patient with critical ischemia, * Patient with hearing problems, * Patient with cognitive disorders, * Patient placed under legal protection, guardianship or curatorship, * Pregnant or breastfeeding woman.

Contact & Investigator

Central Contact

Emmanuelle Guitteaud

✉ emmanuelle.guitteaud@chu-martinique.fr

📞 05 96 55 35 45

Principal Investigator

Emmanuelle Guitteaud

PRINCIPAL INVESTIGATOR

University Hospital Center of Martinique

Frequently Asked Questions

Who can join the NCT06153589 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Debridement Care. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06153589 currently recruiting?

Yes, NCT06153589 is actively recruiting participants. Contact the research team at emmanuelle.guitteaud@chu-martinique.fr for enrollment information.

Where is the NCT06153589 trial being conducted?

This trial is being conducted at Fort-de-France, France.

Who is sponsoring the NCT06153589 clinical trial?

NCT06153589 is sponsored by University Hospital Center of Martinique. The principal investigator is Emmanuelle Guitteaud at University Hospital Center of Martinique. The trial plans to enroll 180 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology